Buchumschlag

Correction to “Expression, regulation and roles of miR ‐26a and MEG3 in tongue squamous cell carcinoma”

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	International Journal of Cancer
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Expression of Concern: HOXD ‐ AS1 / miR ‐130a sponge regulates glioma development by targeting E2F8
Veröffentlicht: (2024)

Expression of Concern: miR ‐145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6
Veröffentlicht: (2024)

Poor oral health and the risk of esophageal squamous cell carcinoma in Malawi
von: Bongani Kaimila, et al.
Veröffentlicht: (2024)

The prognostic value of cell‐free DNA dynamics during chemoradiotherapy in squamous cell carcinomas of the anus
von: Anne Vittrup Jakobsen, et al.
Veröffentlicht: (2025)

The interaction of PRDX1 with Cofilin promotes oral squamous cell carcinoma metastasis
von: Yajun Shen, et al.
Veröffentlicht: (2024)

Evolution of genome and immunogenome in esophageal squamous cell carcinomas driven by neoadjuvant chemoradiotherapy
von: Zelin Weng, et al.
Veröffentlicht: (2024)

Exploring solute carriers as biomarkers and therapeutic targets in esophageal squamous cell carcinoma
von: Lin‐Ting Zhang, et al.
Veröffentlicht: (2025)

Biopsy‐verified vulvar lichen sclerosus: Incidence trends 1997–2022 and increased risk of vulvar squamous precancer and squamous cell carcinoma
von: Louise Baandrup, et al.
Veröffentlicht: (2024)

Spatial evidence for carcinoma in situ ( CIS ) as an entity in human papillomavirus ( HPV )‐associated tonsillar squamous cell carcinoma ( TSCC )
von: Tobias Näsman, et al.
Veröffentlicht: (2025)

Genomic progression for local invasion of cutaneous squamous cell carcinoma from the superficial to the deep portion
von: Hye Won Hwang, et al.
Veröffentlicht: (2024)

Cancer‐associated fibroblast activation predicts progression, metastasis, and prognosis of cutaneous squamous cell carcinoma
von: Jaakko S. Knuutila, et al.
Veröffentlicht: (2024)

The transcriptional landscape and clinico‐biological characterization of human endogenous retroviruses in esophageal squamous cell carcinoma
von: Xinrui Shi, et al.
Veröffentlicht: (2024)

The association between waterpipe smoking and head and neck squamous cell carcinoma: A multicenter case–control study in Iran
von: Maryam Hadji, et al.
Veröffentlicht: (2025)

Evaluating ChatGPT's recommendations for systematic treatment decisions in recurrent or metastatic head and neck squamous cell carcinoma: Perspectives from experts and junior doctors
von: Danfang Yan, et al.
Veröffentlicht: (2025)

Radiotherapy as an organ‐preserving alternative to surgery in patients with locally advanced esophageal squamous cell carcinoma achieving major pathologic response after induction immunochemotherapy
von: Xin‐Yun Song, et al.
Veröffentlicht: (2025)

Transgenic overexpression of the miR‐200b/200a/429 cluster prevents mammary tumor initiation in Neu/Erbb2 transgenic mice
von: Katrina L. Watson, et al.
Veröffentlicht: (2024)

Comments on “Evaluating ChatGPT 's recommendations for systematic treatment decisions in recurrent or metastatic head and neck squamous cell carcinoma: Perspectives from experts and junior doctors”
von: Satya Ranjan Misra, et al.
Veröffentlicht: (2025)

Triptolide inhibits esophageal squamous cell carcinoma progression by regulating the circNOX4/miR‐153‐3p/SATB1 signaling pathway
von: Hanping Liang, et al.
Veröffentlicht: (2024)

Age and tumour presentations differ between HPV type 16 positive and other high‐risk HPV type‐positive oropharyngeal squamous cell carcinomas in a Swedish cohort of 2000–2022
von: Anders Näsman, et al.
Veröffentlicht: (2025)

Simultaneous integrated boost intensity‐modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal squamous cell carcinoma: A multicenter, open‐label, randomized, phase III clinical trial
von: Weiming Han, et al.
Veröffentlicht: (2025)

Carbonic anhydrase‐9‐targeted near‐infrared photoimmunotherapy as a theranostic modality for clear cell renal cell carcinoma
von: Hiroshi Fukushima, et al.
Veröffentlicht: (2025)

miR‐30c‐5p inhibits esophageal squamous cell carcinoma progression by repressing the PI3K/AKT signaling pathway
von: Haochun Shi, et al.
Veröffentlicht: (2024)

Exploiting NRF2‐ARE pathway activation in papillary renal cell carcinoma
von: Silvia Angori, et al.
Veröffentlicht: (2024)

B cells critical for outcome in high grade serous ovarian carcinoma
von: Annegé Vledder, et al.
Veröffentlicht: (2024)

Metabolic regulation of the tumour and its microenvironment: The role of Epstein–Barr virus
von: Shen‐Han Lee, et al.
Veröffentlicht: (2024)

New players in the landscape of renal cell carcinoma bone metastasis and therapeutic opportunities
von: Beatrice Cesana, et al.
Veröffentlicht: (2024)

Apoptosis regulators of the Bcl‐2 family play a key role in chemoresistance of cholangiocarcinoma organoids
von: Wunan Mi, et al.
Veröffentlicht: (2025)

The critical role of discoidin domain receptors in the regulation of anti‐tumor immune responses
von: Sixin Jiang, et al.
Veröffentlicht: (2026)

Correction to: HDAC5 , Negatively regulated by miR ‐ 148a‐ 3p, promotes colon cancer cell migration
Veröffentlicht: (2024)

Real‐world comparison of cabozantinib and sunitinib in advanced non‐clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group
von: Gökhan Şahin, et al.
Veröffentlicht: (2025)

Clinical and genetic features of multiple primary tumours cohorts with a renal cell carcinoma: Implications for molecular genetic investigations
von: Huairen Zhang, et al.
Veröffentlicht: (2025)

Obesity enhances the response to neoadjuvant anti‐ PD1 therapy in oral tongue squamous cell carcinoma
von: Xiyan Tan, et al.
Veröffentlicht: (2024)

Circulating cell‐free DNA methylation biomarkers for hepatocellular carcinoma risk prediction in HIV ‐positive Nigerian population
von: Yinan Zheng, et al.
Veröffentlicht: (2025)

Clinical features and response to immune combinations in patients with renal cell carcinoma and sarcomatoid de‐differentiation (ARON‐1 study)
von: Chiara Ciccarese, et al.
Veröffentlicht: (2024)

Lesion distribution and prognosis of renal cell carcinoma bone metastasis: A novel evaluation model based on random survival forests
von: Zixiong Huang, et al.
Veröffentlicht: (2026)

Toxicity‐related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune‐based combinations ( ARON ‐1 study)
von: Javier Molina‐Cerrillo, et al.
Veröffentlicht: (2025)

Comments on “Toxicity‐related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune‐based combinations ( ARON ‐1 study)”
von: Wen‐Jiang Yang
Veröffentlicht: (2025)

Correction to “Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus”
Veröffentlicht: (2024)

Augmented drug resistance of osteosarcoma cells within decalcified bone matrix scaffold: The role of glutamine metabolism
von: Jiaxin Ren, et al.
Veröffentlicht: (2024)

Reply to: Comments on “Toxicity‐related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune‐based combinations ( ARON ‐1 study)”
von: Javier Molina‐Cerrillo, et al.
Veröffentlicht: (2025)